U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H18O3
Molecular Weight 198.2588
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of JTT-608

SMILES

C[C@H]1CC[C@@H](CC1)C(=O)CCC(O)=O

InChI

InChIKey=JOWMTYWOBJALGB-KYZUINATSA-N
InChI=1S/C11H18O3/c1-8-2-4-9(5-3-8)10(12)6-7-11(13)14/h8-9H,2-7H2,1H3,(H,13,14)/t8-,9-

HIDE SMILES / InChI

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
PubMed

PubMed

TitleDatePubMed
A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide.
2001 Jan
Daily inhibition of postprandial hyperglycaemia with JTT-608, a novel oral antidiabetic agent, ameliorates pancreatic function in neonatally streptozotocin-treated rats.
2005 Sep
Patents
Name Type Language
JTT-608
Common Name English
CYCLOHEXANEBUTANOIC ACID, 4-METHYL-.GAMMA.-OXO-, TRANS-
Systematic Name English
Code System Code Type Description
FDA UNII
U419K07BFP
Created by admin on Sat Dec 16 08:42:56 GMT 2023 , Edited by admin on Sat Dec 16 08:42:56 GMT 2023
PRIMARY
CAS
195137-72-5
Created by admin on Sat Dec 16 08:42:56 GMT 2023 , Edited by admin on Sat Dec 16 08:42:56 GMT 2023
PRIMARY
PUBCHEM
6919096
Created by admin on Sat Dec 16 08:42:56 GMT 2023 , Edited by admin on Sat Dec 16 08:42:56 GMT 2023
PRIMARY